Background
The aim of this study is to assess the impact of baseline viral load on the premature aging process in infants with perinatally acquired HIV (PHIV), enrolled in the Early Anti-Retroviral Treatment in HIV children (EARTH) cohort.
Methods
Thirty-six ART-naïve PHIV infants, with a median age of 1.6 (1.3-2.5) years at enrollment, were stratified in two groups based on plasma viremia at enrollment: group 1 (<25 percentile of Log2 HIV-RNA) and group 2 (>75 percentile of Log2 HIV- RNA). The immune aging profile, including activated, senescent and exhausted T cells, were analyzed by flow cytometry. Relative telomere length and HIV-DNA levels in peripheral blood mononuclear cells (PBMC) were measured by real-time PCR and droplet digital PCR, respectively. Statistical analyses were performed using SigmaPlot software.
Results
Plasma viremia significantly correlated with HIV-DNA in PBMC (r=0.525, p=0.003). Baseline levels of HIV-DNA levels in PBMC were significantly higher in group 2 than in group 1 (1159 [617-4426] vs 89 [9-1607] copies/106 PBMC, p=0.011). Similarly, group 2 had higher percentages of activated (CD38+HLA-DR+), senescent (CD27-CCR7-CD45RA+CD28-CD57+) and exhausted (PD-1+) CD4 and CD8 T cells than group 1 (Relative Telomere lengths were significantly shorter in group 2 than in group 1 (1.82 [1.68-1.90] vs 1.93 [1.78-2.26], p=0.020).
Conclusions
Higher baseline viral load strongly correlated with HIV-DNA levels in PBMC and led to increase immune activation and senescence, thus suggesting that baseline plasma viremia impacts the aging process in PHIV starting from very early age.
Table or Figure
![]()